For advanced NSCLC patients, there was a significant difference in OS between KRAS-G12C and KRAS-non-G12C patients (7.7 months vs 6.0 months, p = 0.018), while KRAS-G12V patients had the shortest OS (21). Here, KRAS is linked to non-small cell lung carcinoma.